Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05009095Not ApplicableCompleted

The Listening Program® With Bone Conduction Headphones Changes Hypersensitivity to Sound and Behavioral Responses

Role: lead

NCT07249931Not ApplicableNot Yet Recruiting

Efficacy and Safety of Nerivio for the Management of Amplified Musculoskeletal Pain Syndrome in Pediatric Patients

Role: lead

NCT05917678Not ApplicableRecruiting

Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation

Role: collaborator

NCT06239675Not ApplicableWithdrawn

Cerebral pAlsy Motor Promotion With Transcranial Direct Current Stimulation (CAMP-tDCS)

Role: collaborator

NCT05373992Not ApplicableCompleted

Concussion Screen Use Recovery Time

Role: lead

NCT04529980Not ApplicableCompleted

Probiotics and Antibiotic Associated Diarrhea in Pediatric Complicated Appendicitis

Role: lead

NCT04895670Completed

Empowering Youth Aging Out of Foster Care

Role: collaborator

NCT05351866Not ApplicableTerminated

Digital Therapeutic for Adolescent Depressive Symptoms in Hematology, Oncology, and Weight Management

Role: collaborator

All 8 trials loaded